These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24530046)

  • 21. Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A.
    Kijima K; Numakura C; Izumino H; Umetsu K; Nezu A; Shiiki T; Ogawa M; Ishizaki Y; Kitamura T; Shozawa Y; Hayasaka K
    Hum Genet; 2005 Jan; 116(1-2):23-7. PubMed ID: 15549395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitofusin 2 gene mutation causing early-onset CMT2A with different progressive courses.
    Lv H; Wang L; Li W; Qiao X; Li Y; Wang Z; Yuan Y
    Clin Neuropathol; 2013; 32(1):16-23. PubMed ID: 22762946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).
    Engelfried K; Vorgerd M; Hagedorn M; Haas G; Gilles J; Epplen JT; Meins M
    BMC Med Genet; 2006 Jun; 7():53. PubMed ID: 16762064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene.
    Lawson VH; Graham BV; Flanigan KM
    Neurology; 2005 Jul; 65(2):197-204. PubMed ID: 16043786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational mechanisms in MFN2-related neuropathy: compound heterozygosity for recessive and semidominant mutations.
    Piscosquito G; Saveri P; Magri S; Ciano C; Di Bella D; Milani M; Taroni F; Pareyson D
    J Peripher Nerv Syst; 2015 Dec; 20(4):380-6. PubMed ID: 26306937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterizing the phenotypic manifestations of MFN2 R104W mutation in Charcot-Marie-Tooth type 2.
    Genari AB; Borghetti VH; Gouvêa SP; Bueno KC; dos Santos PL; dos Santos AC; Barreira AA; Lourenço CM; Marques W
    Neuromuscul Disord; 2011 Jun; 21(6):428-32. PubMed ID: 21531138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, electrophysiological and pathological findings of a patient with CMT2 due to the p.Ala738Val mitofusin 2 mutation.
    Luigetti M; Fabrizi GM; Taioli F; Conte A; Del Grande A; Sabatelli M
    J Neurol Sci; 2011 Aug; 307(1-2):168-70. PubMed ID: 21601224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel double mutation in cis in MFN2 causes Charcot-Marie-Tooth neuropathy type 2A.
    Park SY; Kim SY; Hong YH; Cho SI; Seong MW; Park SS
    Neurogenetics; 2012 Aug; 13(3):275-80. PubMed ID: 22526351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families.
    Braathen GJ; Sand JC; Lobato A; Høyer H; Russell MB
    BMC Med Genet; 2010 Mar; 11():48. PubMed ID: 20350294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.
    Baloh RH; Schmidt RE; Pestronk A; Milbrandt J
    J Neurosci; 2007 Jan; 27(2):422-30. PubMed ID: 17215403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations.
    Polke JM; Laurá M; Pareyson D; Taroni F; Milani M; Bergamin G; Gibbons VS; Houlden H; Chamley SC; Blake J; Devile C; Sandford R; Sweeney MG; Davis MB; Reilly MM
    Neurology; 2011 Jul; 77(2):168-73. PubMed ID: 21715711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2.
    Züchner S; De Jonghe P; Jordanova A; Claeys KG; Guergueltcheva V; Cherninkova S; Hamilton SR; Van Stavern G; Krajewski KM; Stajich J; Tournev I; Verhoeven K; Langerhorst CT; de Visser M; Baas F; Bird T; Timmerman V; Shy M; Vance JM
    Ann Neurol; 2006 Feb; 59(2):276-81. PubMed ID: 16437557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Massively Parallel Sequencing Detected a Mutation in the MFN2 Gene Missed by Sanger Sequencing Due to a Primer Mismatch on an SNP Site.
    Neupauerová J; Grečmalová D; Seeman P; Laššuthová P
    Ann Hum Genet; 2016 May; 80(3):182-6. PubMed ID: 26916081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial GTPase mitofusin 2 mutations in Korean patients with Charcot-Marie-Tooth neuropathy type 2.
    Cho HJ; Sung DH; Kim BJ; Ki CS
    Clin Genet; 2007 Mar; 71(3):267-72. PubMed ID: 17309650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early onset Charcot-Marie-Tooth neuropathy type 2A and severe developmental delay: expanding the clinical phenotype of MFN2-related neuropathy.
    Tufano M; Cappuccio G; Terrone G; Manganelli F; Pisciotta C; Geroldi A; Capponi S; Del Giudice E
    J Peripher Nerv Syst; 2015 Dec; 20(4):415-8. PubMed ID: 26307494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exome sequencing reveals mutations in MFN2 and GDAP1 in severe Charcot-Marie-Tooth disease.
    Kostera-Pruszczyk A; Kosinska J; Pollak A; Stawinski P; Walczak A; Wasilewska K; Potulska-Chromik A; Szczudlik P; Kaminska A; Ploski R
    J Peripher Nerv Syst; 2014 Sep; 19(3):242-5. PubMed ID: 25403865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fifteen-year longitudinal follow-up of a patient with severe early-onset Charcot-Marie-Tooth disease type 2A.
    McCray BA; Hurst W; Crawford TO; Lloyd TE
    Muscle Nerve; 2018 May; 57(5):E126-E128. PubMed ID: 29266326
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical and allelic heterogeneity in a pediatric cohort of 11 patients carrying MFN2 mutation.
    Di Meglio C; Bonello-Palot N; Boulay C; Milh M; Ovaert C; Levy N; Chabrol B
    Brain Dev; 2016 May; 38(5):498-506. PubMed ID: 26686600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MFN2 deletion of exons 7 and 8: founder mutation in the UK population.
    Carr AS; Polke JM; Wilson J; Pelayo-Negro AL; Laura M; Nanji T; Holt J; Vaughan J; Rankin J; Sweeney MG; Blake J; Houlden H; Reilly MM
    J Peripher Nerv Syst; 2015 Jun; 20(2):67-71. PubMed ID: 26114802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitofusin 2 gene mutation (R94Q) causing severe early-onset axonal polyneuropathy (CMT2A).
    Neusch C; Senderek J; Eggermann T; Elolff E; Bähr M; Schneider-Gold C
    Eur J Neurol; 2007 May; 14(5):575-7. PubMed ID: 17437620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.